Key facts
- Antidote (Business/Productivity Software)’s last known valuation is $8.1M (May 2025).
- It has raised $6.9M; the latest was Seed Round ($5.0M) in Jan 2026.
- Notable investors include Lakestar, The Legal Tech Fund, Concept Ventures (London).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Antidote (Business/Productivity Software)
- ·The full record, as it builds
Funding rounds
No funding rounds for Antidote (Business/Productivity Software) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Antidote (Business/Productivity Software)
Developer of AI-based legal billing compliance software designed to help law firms reduce write-offs and manage legal operations. The company's platform automates legal billing compliance, designed to analyze time entries in real time and flag non-compliant or poorly drafted entries before invoices are submitted.
- Sector
- Information Technology
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 10
- Website
- antidotelegal.com/
- Ownership
- Privately Held (backing)
Antidote (Business/Productivity Software) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Antidote (Business/Productivity Software) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Antidote (Business/Productivity Software) in its N-PORT filings yet. We sweep new filings monthly.